Neuroone Medical Technologies (NMTC) Other Working Capital Changes (2018 - 2024)
Neuroone Medical Technologies (NMTC) posted Other Working Capital Changes of -$21762.0 for Q4 2024, down 475.71% on a QoQ basis from -$3780.0 in Q4 2023, and down 475.71% year-over-year from $5792.2 in Q1 2024.
Neuroone Medical Technologies (NMTC) Other Working Capital Changes (2018 - 2024) Analysis & Trends
Neuroone Medical Technologies' Other Working Capital Changes history runs 7 years deep, the most recent figure standing at -$21762.0 for Q4 2024.
- Quarterly Other Working Capital Changes fell 475.71% year-over-year to -$21762.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$132499.0 (down 109.34% YoY) and the FY2023 annual result came in at -$32903.0, down 122.61% from the prior year.
- Other Working Capital Changes was -$21762.0 for Q4 2024 at Neuroone Medical Technologies, down from -$3780.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $1.5 million in Q1 2023 and bottomed at -$1.5 million in Q4 2022.
- A 5-year average of $9776.3 and a median of -$1140.0 in 2020 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2022 — Other Working Capital Changes sank 10561.5% — and 2023, when it surged 66719.23%.
- Neuroone Medical Technologies' Other Working Capital Changes stood at $7253.0 in 2020, then sank by 288.18% to -$13649.0 in 2021, then sank by 10561.5% to -$1.5 million in 2022, then soared by 99.74% to -$3780.0 in 2023, then slumped by 475.71% to -$21762.0 in 2024.
- Business Quant data shows NMTC's Other Working Capital Changes at -$21762.0 in Q4 2024, -$3780.0 in Q4 2023, and $52119.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Neuroone Medical Technologies | 7.99 Mn | 5.19 Mn | 990,264.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -21,762.00 |
| Dec 31, 2024 | -21,762.00 |
| Dec 31, 2024 | -21,762.00 |
| Dec 31, 2023 | -3,780.00 |
| Dec 31, 2023 | -3,780.00 |
| Dec 31, 2023 | -3,780.00 |
| Sep 30, 2023 | 52,119.00 |
| Sep 30, 2023 | 52,119.00 |
| Sep 30, 2023 | 52,119.00 |
| Jun 30, 2023 | -159,076.00 |
| Jun 30, 2023 | -159,076.00 |
| Jun 30, 2023 | -159,076.00 |
| Mar 31, 2023 | 1.53 Mn |
| Mar 31, 2023 | 1.53 Mn |
| Mar 31, 2023 | 1.53 Mn |
| Dec 31, 2022 | -1.46 Mn |
| Dec 31, 2022 | -1.46 Mn |
| Dec 31, 2022 | -1.46 Mn |
| Sep 30, 2022 | 78.00 |
| Sep 30, 2022 | 78.00 |